Can Biotech ETFs Continue to Soar in 2020?
We discuss coronavirus, cancer drugs, gene therapies, crispr and related biotech stocks a ETFs.(1:20) - Who Could Benefit From A Coronavirus Treatment?(5:45) - What Should Investors Expect From Biotech In 2020?(10:50) - Will The FDA Approve Biogen’s New Alzheimer’s Drug?(15:00) - New and Exciting Cancer Treatments(22:15) - CRISPR: Is 2020 The Year For Gene Therapy?(32:40) - Merck’s Product Spin OffPodcast@Zacks.com
